Skip to content

Ask an Academic

  • Home
  • Ask a Question
  • Contact Us
Laboratory experiment

What is the significance of the High Court’s ruling over NHS England’s appeal on the cost implications of public administration?

September 25, 2019 by AskanAcademic.com

PrEP, which is short for “pre-exposure prophylaxis” using the antri-retroviral drug Truvada. It has been shown to prevent HIV in...

Question

PrEP has shown to reduce the risk of HIV infection by more than 90 per cent in people who are at high risk. What is the significance of the High Court’s ruling over NHS England’s appeal on the cost implications of public administration?

Answer

PrEP, which is short for “pre-exposure prophylaxis” using the antri-retroviral drug Truvada. It has been shown to prevent HIV in individuals who are at a high risk of contracting this disease due to their lifestyle, and its discovery represents a significant opportunity to reduce the spread of HIV/Aids and potentially even lead to the eradication of the disease altogether. Unfortunately, however, the drug is expensive, and NHS England has tried to claim that does not have the power to pay for this drug, since the responsibility for preventative public health services lies with local authorities, and not with the NHS. The High Court ruling has rejected this view, insisting that the NHS will now be obliged to “formally consider” whether to fund this therapy or not (Telegraph Reporters, 2016, p. 1).

This ruling is significant because it clarifies the responsibilities of the NHS and requires NHS England to a) decide whether the NHS will fund the drug and b) justify this decision, whichever choice is taken after due debate. The NHS website (2016) notifies the public that the NHS will also lobby the drug manufacturer and explore generic alternatives, because of the pressure that the high price of the drug would put on their budgets, which are already stretched because of other common health conditions. These are all positive impacts which could reduce the cost burden of this treatment for public administration in the long term.

In the meantime, however, there remains some uncertainty about the role of local authorities, and the likelihood of the NHS being able to fund, or partially fund this therapy, because the High Court Ruling does not consider issues such as funding to provide this service. It does not compel the NHS to fund the drug, but merely rules that it must consider such funding. These debates will continue, and public administration managers will still have to make difficult choices about prioritising this therapy or other vital preventative and treatment therapies for similarly serious conditions. This problem is part of a much bigger trend of increasing pressure on public administration budgets but if the NHS commits to prescribing this drug, it could reduce the cost of HIV/Aids in the longer term, as fewer people would be infected, and all the costs of fully-developed Aids for these people would be avoided.

References

NHS (2016) Update on PrEP. (10 November) Available at: https://www.england.nhs.uk/2016/11/update-on-prep/ [Accessed 10 November 2016].

Telegraph Reporters (2016) NHS to consider funding ‘game changer’ HIV drugs as High Court Dismisses appeal. The Telegraph (10 November) Available at: http://www.telegraph.co.uk/news/2016/11/10/nhs-to-consider-funding-game-changer-hiv-drugs-as-high-court-dis/ [Accessed 10 November 2016].

Post navigation

Previous Post:

Waterfowl genitalia- How female and male sexual organs have co-evolved.

Next Post:

Creating a ‘Northern Powerhouse’ is counterproductive for businesses in the north of England?

Search Q&As

Categories

  • Art Media and Literature (74)
  • Business and Management (256)
  • Computing and ICT (14)
  • Construction and Engineering (35)
  • Education (90)
  • Environmental Sciences (2)
  • Finance and Economics (91)
  • Health (64)
  • Languages (12)
  • Law (88)
  • Mathematics and Statistics (2)
  • Medical Sciences (19)
  • Politics and International Relations (83)
  • Research Methodology (1)
  • Science (49)
  • Social Sciences (101)

Archives

Who We Are

Askanacademic.com is owned and operated by All Answers Ltd, a company registered in England and Wales. Company Registration No: 4964706. VAT Registration No: 842417633. Data Controller No: Z1821391.

Registered office:
Venture House
Cross Street
Arnold
Nottingham
NG5 7PJ

Main Navigation

  • Home
  • Ask a Question
  • Contact Us

Legals

  • Cookie Policy
  • Privacy Policy

Popular Categories

  • Business and Management
  • Law
  • Finance and Economics
  • Health
An an Academic Logo
© 2023 Ask an Academic | WordPress Theme by Superb Themes
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Reject
Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT